Objective Evaluation of the Longevity of A Calcium Hydroxylapatite-Based Filler (Radiesse®)

  • M A
N/ACitations
Citations of this article
9Readers
Mendeley users who have this article in their library.

Abstract

Background: Calcium hydroxylapatite (CaHA) based soft-tissue filler (Radiesse® , Merz) is categorised as a biodegradable collagen-stimulating implant. It is comprised of a suspension of 25-45 micron diameter microspheres of CaHA(30%) in a carboxymethylcellulose (CMC) gel carrier (70%) and is one of the most well researched soft-tissue fillers. However, great discrepancies exist in the literature regarding the duration of clinical effect with the implant, ranging from only 6 to 24 months.

Cite

CITATION STYLE

APA

M, A.-K. (2021). Objective Evaluation of the Longevity of A Calcium Hydroxylapatite-Based Filler (Radiesse®). Journal of Clinical and Cosmetic Dermatology, 5(2). https://doi.org/10.16966/2576-2826.163

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free